Keyword: Cephalon

News

EU Accuses Teva and Cephalon of Antitrust Breach

20.07.2017 - The European Commission has accused Israeli drugmaker Teva and its US subsidiary Cephalon of breaching antitrust rules. Regulators classed an agreement between the companies to...

News

Teva to Refund Buyers for Cephalon Drug Overpay

29.05.2015 - Just before trial proceedings were to begin in a long-running dispute between the US Federal Trade Commission (FTC) and drugmaker Cephalon - now a subsidiary of Teva - the Israeli...

News

U.S. Supreme Court Win Boosts Fight Against Drug Settlements

24.07.2013 - A U.S. Supreme Court ruling giving regulators the right to sue drugmakers for agreements that delay sale of cheaper generic pharmaceuticals should deter some of the most egregious...

News

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

23.03.2013 - The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...

News

Teva Pharmaceutical Adjusted Profit Tops Estimates

01.11.2012 - Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...

News

Teva Q1 Profit Up On Higher European Sales

11.05.2011 - Teva Pharmaceutical Industries, the world's largest generic drugmaker, met forecasts with a 14% rise in quarterly earnings on strong sales growth in Europe following last year's...

News

Teva To Buy Cephalon For $6.8 Billion

04.05.2011 - Teva Pharmaceutical Industries struck a deal to acquire U.S. specialty drugmaker Cephalon for nearly $7 billion, topping an unsolicited bid by Canada's Valeant Pharmaceuticals...

News

Cephalon Offers $231 Million Takeover of ChemGenex

29.03.2011 - Cephalon has offered to buy the Australian company ChemGenex Pharmaceuticals for about $231 million, or 225 Australian dollars. Cephalon's bid "has the unanimous support of the...